PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomasDaniela Laimer, Lukas Kenner|Nature Medicine|2012Cited by 125
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy ResistanceEmine Atas, Lukas Kenner|Frontiers in Oncology|2020Cited by 113
Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Lukas Kenner|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Lukas Kenner|Molecular Cancer|2025Cited by 0